[PROBLEM OF ENDOMETRIUM HYPERPLASTIC PROCESSES IN REPRODUCTIVE AGE WOMEN]

L. Z. Bazyuta, S P Polyova, S A Tsintar, S. А. Tsintar
Likars'ka sprava · 2016 · pp. 3–9 · PMID:27491143 · W2497967060
Review OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-09 ⓘ

This article identifies risk factors for endometrium hyperplastic processes in reproductive age women, linking their occurrence to hormonal homeostasis violations and the role of immune-related biologically active substances in regulating endometrial cell growth.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The article presents the risk factors of endometrium hyperplastic processes (EHP) in reproduc- tive age women. It is shown that EHP occur in response to hormonal homeostasis violations of the target tissues. It is established that the biologically active substances, which are closely related to immune mechanisms of the reproductive system functioning take place in regulatory mechanisms of cell growth and differentiation of endometrium.

My notes (saved in your browser only)

MeSH descriptors

Endometrial Hyperplasia Endometrium Estrogens Hormone Replacement Therapy Reproduction Adolescent Adult Endometrial Hyperplasia Endometrial Hyperplasia Endometrial Hyperplasia Endometrial Hyperplasia Endometrium Endometrium Endometrium Epidermal Growth Factor Epidermal Growth Factor Epidermal Growth Factor Estrogens Estrogens Estrogens

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:18:17.876363+00:00
License: CC0 · commercial use OK